BRT provides customized in vivo studies to evaluate therapeutic efficacy, pharmacologic response, and immune-related outcomes across preclinical research programs.
BRT conducts customized in vivo studies to evaluate therapeutic efficacy and pharmacologic response across a range of preclinical research programs.
BRT supports specialized dosing and infusion approaches in rodent studies to accommodate customized study designs and research objectives.
BRT can incorporate monitoring and specialized endpoints into customized in vivo studies to support evaluation of treatment-related responses.
BRT works with clients to develop customized in vivo studies based on specific research objectives, test articles, dosing approaches, and endpoints.
